Heparin and infarct coronary artery patency after streptokinase in acute myocardial infarction

This publication has 24 references indexed in Scilit:

• Prevention of coronary artery reocclusion and reduction in late coronary artery stenosis after thrombolytic therapy in patients with acute myocardial infarction. A randomized study of maintenance infusion of recombinant human tissue-type plasminogen activator.
  Circulation, 1988
• Short-term infarct vessel patency with aspirin and dipyridarnole started 24 to 36 hours after intravenous streptokinase
  American Heart Journal, 1988
• Intermittent Coronary Occlusion in Acute Myocardial Infarction
  New England Journal of Medicine, 1987
• Interventions that potentially limit myocardial infarct size: Overview of clinical trials
  The American Journal of Cardiology, 1987
• Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.
  Circulation, 1987
• Management of patients after thrombolytic therapy for acute moycardial infarction
  Clinical Cardiology, 1985
• Thrombolytic therapy in patients with acute myocardial infarction.
  Circulation, 1985
• Evaluation of the effectiveness of intracoronary streptokinase infusion in acute myocardial infarction: Postprocedure management and hospital course in 204 patients
  American Heart Journal, 1981
• Selective intracoronary thrombolysis in acute myocardial infarction and unstable angina pectoris.
  Circulation, 1981
• Prevalence of Total Coronary Occlusion during the Early Hours of Transmural Myocardial Infarction
  New England Journal of Medicine, 1980